Search

The World Health Organization published a new report on phage therapy evidence, showing phages can enhance antibiotic treatments against resistant bacteria as part of a One Health approach.

Sandra Morales and Paul Hyman have published a new perspective called "Quis Custodiet? Are Regulations Slowing Phage Therapy?".  In it, they discuss current regulations, recent efficacy trials and support resources in the context of regulat

PhageEU is urging phage researchers to join their mission to raise awareness about the potential applications of phages and influence regulatory environments in the EU, especially with new parliamentary appointments on the horizon PhageEU m

The Veterinary Biologicals Committee of the International Alliance for Biological Standardization will host a workshop on the quality, safety, and efficacy of phages for veterinary use on September 5, 2024, to discuss strategies for reducin

Proteon Pharmaceuticals, JAFRAL, and PTC Phage Technology Center have established a non-profit organization called PhageEU in Brussels. With newly elected members of EU Parliament and European Commission coming into office, PhageEU sees an

The UK government has responded to the Science, Innovation, and Technology Committee's report on the antimicrobial potential of phages, outlining recommendations for assessing the safety and effectiveness of phages in healthcare settings.

On a new episode of the Accelerating Success podcast, Dr. Steven Theriault discusses how regulatory hurdles in Canada hinder access to innovative animal health products, leading Cytophage Technologies to decide against bringing their produc

Jean-Paul Pirnay and colleagues explore the question of whether magistral phage preparations could serve as a model for everyone.

The European Medicines Agency (EMA) is organizing a Focus Group meeting on 11 May 2023 to discuss the draft guideline on the quality, safety, and efficacy requirements for bacteriophage therapy in veterinary medicines. The aim is to establi

On February 8 at 9:30am GMT the UK Parliament Science and Technology Committee will be holding a public oral evidence session for "The antimicrobial potential of bacteriophages."

The UK Government's Commons Science and Technology Committee announces the terms of reference for a new inquiry exploring the potential of bacteriophages as an alternative to antibiotics.